William Ferguson
Orthopaedic Surgery · Memphis, TNNPI 1992198378
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.1%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 54.2% of the total. Reporting peaked in 2020 at $31,059 and has fallen 99.8% since, to $56 in 2025.
Across 70 payments — averaging $702.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$27K
- Smith+Nephew$20K
- ALON Medical Technology$1K
- Gentleman Orthopedic Solutions$1K
- Stryker$214
- Bioventus LLC$51
- plus $122 from 4 others
What the payments were for
- Grants$20,00041%
- Travel & lodging$2,0074%
- Food & beverage$1,5493%
- Education$25,59452%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 37 | $26,627 |
| Smith+Nephew | 6 | $19,656 |
| ALON Medical Technology | 1 | $1,260 |
| Gentleman Orthopedic Solutions | 13 | $1,218 |
| Stryker | 3 | $214 |
| Bioventus LLC | 3 | $51 |
| Amgen | 3 | $41 |
| Sanara Medtech Inc. | 2 | $29 |
| Pacira Therapeutics, Inc. | 1 | $28 |
| Boston Scientific | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$137
How this compares
$49,149 in reported general payments places this provider in the 85th percentile of 381 orthopaedic surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 33 | $37,396 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $222 |
| Meloxicam | 21 | $43 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Memphis
- Michael BeebeMemphis$626K
- Paul BradyKnoxville$20M
- Edwin SpencerKnoxville$2.5M
- Jesse DotyChattanooga$2.3M
- Thomas ThrockmortonGermantown$1.7M
- Alton HunterColumbia$820K
- Jefferson MorrisonNashville$678K
- Gregory PolkowskiNashville$526K
- Matthew WillisNashville$498K
- Michael ChristieNashville$474K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.